Discoid lupus erythematosus | |
---|---|
Other names | DLE, Discoid lupus |
Discoid lupus erythematosus lesion on the head | |
Specialty | Dermatology, Immunology |
Discoid lupus erythematosus is the most common type of chronic cutaneous lupus (CCLE), an autoimmune skin condition on the lupus erythematosus spectrum of illnesses. [1] [2] It presents with red, painful, inflamed and coin-shaped patches of skin with a scaly and crusty appearance, most often on the scalp, cheeks, and ears. Hair loss may occur if the lesions are on the scalp. [3] The lesions can then develop severe scarring, and the centre areas may appear lighter in color with a rim darker than the normal skin. [3] These lesions can last for years without treatment. [4]
Patients with systemic lupus erythematous develop discoid lupus lesions with some frequency. [4] However, patients who present initially with discoid lupus infrequently develop systemic lupus. [3] Discoid lupus can be divided into localized, generalized, and childhood discoid lupus. [3]
The lesions are diagnosed by biopsy. [5] Patients are first treated with sunscreen and topical steroids. [5] If this does not work, an oral medication—most likely hydroxychloroquine or a related medication—can be tried. [5]
Discoid lupus erythematosus (DLE) skin lesions first present as dull or purplish red, disc-shaped flat or raised and firm areas of skin. [3] [5] These lesions then develop increasing amounts of white, adherent scale. [3] [5] Finally, the lesions develop extensive scarring and/or atrophy, as well as pigment changes. [3] They may also have overlying dried fluid, known as crust. [4] On darker skin, the lesions often lose skin pigmentation in the center and develop increased, dark skin pigmentation around the rim. [3] On lighter skin, the lesions often develop a gray color or have very little color change. [3] More rarely, the lesions may be bright red and look like hives. [3]
The skin lesions are most often in sun-exposed areas localized above the neck, with favored sites being the scalp, bridge of the nose, upper cheeks, lower lip, and ear and hands [3] [5] 24% of patients also have lesions in the mouth (most often the palate), nose, eye, or vulva, which are all mucosal parts of the body. [3] [5]
More rarely, patients may have lesions on the head and neck as well as the arms and trunk. [3]
When discoid lupus is on the scalp, it starts as a red flat or raised area of skin that then loses hair and develops extensive scarring. [3] The lesions often lose skin pigment and become white with areas of increased skin pigment, with or without areas of redness, and have a sunken appearance. [3] They can have a smooth surface or have visible, dilated hair follicles on the surface. [3]
When discoid lupus is on the lip, it often has a grey or red colour with a thickened top layer of skin (known as hyperkeratosis), areas where the top layer has worn away (known as erosion), and a surrounding rim of redness. [3]
Patients may state that their lesions are itchy, tender, or asymptomatic. [3] [5] In addition to their skin lesions, they may also have swelling and redness around their eyes, as well as blepharitis. [3] [6]
Darker-skinned patients are often left with severe scarring and skin color changes even after the lesions get better. [5] In addition, these patients have an increased, though still small, risk for aggressive skin squamous cell carcinoma. [3]
Sun exposure triggers lesions in people with discoid lupus erythematous (DLE). [5] Evidence does not clearly demonstrate a genetic component to DLE; however, genetics may predispose certain people to disease. [5]
Most experts consider DLE an autoimmune disease since pathologists see antibodies when they biopsy the lesions and look at the tissue under the microscope. [5] However, scientists do not understand the connection between these antibodies and the lesions seen in discoid lupus. [5]
Possibly, UV light damages skin cells, which then release material from their nuclei. [5] This material diffuses to the dermoepidermal junction, where it binds to circulating antibodies, thereby leading to a series of inflammatory reactions by the immune system. [5]
Alternatively, dysfunctional T cells may lead to the disease. [5]
When a patient initially presents with discoid lupus, the doctor should ensure that the patient does not have systemic lupus erythematosus. [5] The doctor will order tests to check for anti-nuclear antibodies in the patient's serum, low white blood cell levels, and protein and/or blood in the urine. [3] [5]
In order to help with diagnosis, the doctor may peel off the top layer of scale from a patient's lesions in order to look at its underside. [3] If the patients do indeed have discoid lupus, the doctor may see tiny spines of keratin that look like carpet tacks and are called langue au chat. [3]
Diagnosis is confirmed through biopsy. [5] Typical biopsy findings include deposits of IgG and IgM antibodies at the dermoepidermal junction on direct immunofluorescence. [3] [5] This finding is 90% sensitive; however, false positives can occur with biopsies of facial lesions. [5] In addition, pathologists often see groups of white blood cells, particularly T helper cells, around the follicles and blood vessels in the dermis. [3] [5] The epidermis appears thin and has effaced rete ridges as well as excess amounts of keratin clogging the openings of the follicles. [3] [5] The basal layer of the epidermis sometimes appears to have holes in it since some of the cells in this layer have broken apart. [5] The remains of skin cells that have died through a process called apoptosis are visible in the upper layer of the dermis and the basal layer of the epidermis. [3]
The differential diagnosis includes actinic keratoses, sebborheic dermatitis, lupus vulgaris, sarcoidosis, drug rash, Bowen's disease, lichen planus, tertiary syphilis, polymorphous light eruption, lymphocytic infiltration, psoriasis, and systemic lupus erythematosus. [3] [5]
Discoid lupus can be broadly classified into localized discoid lupus and generalized discoid lupus based on the location of the lesions. [3] Patients who develop discoid lupus in childhood also have their own sub-type of disease. [3]
Hypertrophic lupus and lupus profundus are two special types of discoid lupus distinguished by their characteristic morphological findings. [4]
Finally, many patients with systemic lupus also develop discoid lupus lesions. [4]
Most people with discoid lupus only have lesions above the neck and therefore have localized discoid lupus erythematosus. [3]
Rarely, patients may have lesions above and below the neck; these patients have generalized discoid lupus erythematosus. [3] [5] In addition to lesions in the typical above-the-neck locations, patients with generalized discoid lupus often have lesions on the thorax and the arms. [3] These patients are often bald, with abnormal skin pigment on their scalp, and have severe scarring of the face and arms. [3] Patients with generalized discoid lupus often have abnormal lab tests, such as an elevated ESR or a low white blood cell count. [3] They also often have auto-antibodies, such as ANA or anti-ssDNA antibody. [3]
When patients develop discoid lupus in childhood, it differs from typical discoid lupus in several ways. Boys and girls are equally affected, and these patients later develop SLE more often. [3] These patients also typically do not have any abnormal sensitivity to the sun. [3]
Some experts consider hypertrophic lupus erythematosus—which consists of lesions covered by a very thick, keratin-filled scale—an unusual subset of discoid lupus. [4] Others consider it a distinct entity. [3]
If a patient has discoid lupus lesions on top of lupus panniculitis, they have lupus profundus. [4] These patients have firm, nontender nodules with defined borders underneath their discoid lupus lesions. [3]
In general, patients with discoid lupus who have only skin disease and no systemic symptoms have a genetically distinct disease from patients with SLE. [5] However, 25% of patients with SLE get discoid lupus lesions at some point as part of their disease. [4]
Treatment for discoid lupus erythematosus includes smoking cessation and a sunscreen that protects against both UVA and UVB light as well as very strong topical steroids or steroids injected into the lesions. [5] Other topical treatments, tacrolimus or pimecrolimus can also be used. [2] [7] If this does not help the patient, his or her physician can prescribe an antimalarial medication such as oral hydroxychloroquine or chloroquine. [5] Other oral medications used to treat discoid lupus include retinoids (isotretinoin or acitretin), dapsone, thalidomide (teratogenic, side effects include peripheral neuropathy), azathioprine, methotrexate, or gold. [2] [5] The topical steroid fluocinonide is more effective than hydrocortisone in the treatment of discoid lupus erythematosus. [8] For oral treatment, hydroxychloroquine and acitretin are equally effective; however, acitretin was associated with more adverse effects. [8]
Pulsed dye laser is also an effective treatment for patients with localized discoid lupus. [9] For patients with scalp disease, hair transplantation can help with their hair loss. [10]
Discoid lupus erythematosus is a chronic condition, and lesions will last for several years without treatment. [4] [5] 50% of patients will eventually get better on their own. [5] If a patient does not have any signs of systemic lupus erythematosus, such as generalized hair loss, ulcers in the mouth or nose, Raynaud's phenomenon, arthritis, or fever at the time that they develop discoid lupus, they will most likely only have discoid lupus and will never develop systemic lupus erythematosus. [3] [5]
Discoid lupus has an unknown incidence, although it is two to three times more common than systemic lupus erythematosus. [5] [6] The disease tends to affect young adults, and women are affected more than men in a 2:1 ratio. [3]
The musician Seal has this skin condition. [11]
Singer Michael Jackson was reportedly diagnosed with discoid lupus in 1984; the condition might have damaged his nasal cartilage and led to some of his cosmetic surgery. [12]
Lichen planus (LP) is a chronic inflammatory and autoimmune disease that affects the skin, nails, hair, and mucous membranes. It is not an actual lichen, but is named for its appearance. It is characterized by polygonal, flat-topped, violaceous papules and plaques with overlying, reticulated, fine white scale, commonly affecting dorsal hands, flexural wrists and forearms, trunk, anterior lower legs and oral mucosa. The hue may be gray-brown in people with darker skin. Although there is a broad clinical range of LP manifestations, the skin and oral cavity remain as the major sites of involvement. The cause is unknown, but it is thought to be the result of an autoimmune process with an unknown initial trigger. There is no cure, but many different medications and procedures have been used in efforts to control the symptoms.
Actinic keratosis (AK), sometimes called solar keratosis or senile keratosis, is a pre-cancerous area of thick, scaly, or crusty skin. Actinic keratosis is a disorder of epidermal keratinocytes that is induced by ultraviolet (UV) light exposure.
Mycosis fungoides, also known as Alibert-Bazin syndrome or granuloma fungoides, is the most common form of cutaneous T-cell lymphoma. It generally affects the skin, but may progress internally over time. Symptoms include rash, tumors, skin lesions, and itchy skin.
Lupus vulgaris are painful cutaneous tuberculosis skin lesions with nodular appearance, most often on the face around the nose, eyelids, lips, cheeks, ears and neck. It is the most common Mycobacterium tuberculosis skin infection. The lesions may ultimately develop into disfiguring skin ulcers if left untreated.
Morphea is a form of scleroderma that mainly involves isolated patches of hardened skin on the face, hands, and feet, or anywhere else on the body, usually with no internal organ involvement. However, in Deep Morphea inflammation and sclerosis can be found in the deep dermis, panniculus, fascia, superficial muscle and bone.
Discoid lupus erythematosus (DLE) is an uncommon autoimmune disease of the basal cell layer of the skin. It occurs in humans and cats, more frequently occurring in dogs. It was first described in dogs by Griffin and colleagues in 1979. DLE is one form of cutaneous lupus erythematosus (CLE). DLE occurs in dogs in two forms: a classical facial predominant form or generalized with other areas of the body affected. Other non-discoid variants of CLE include vesicular CLE, exfoliative CLE and mucocutaneous CLE. It does not progress to systemic lupus erythematosus (SLE) in dogs. SLE can also have skin symptoms, but it appears that the two are either separate diseases. DLE in dogs differs from SLE in humans in that plasma cells predominate histologically instead of T lymphocytes. Because worsening of symptoms occurs with increased ultraviolet light exposure, sun exposure most likely plays a role in DLE, although certain breeds (see below) are predisposed. After pemphigus foliaceus, DLE is the second most common autoimmune skin disease in dogs.
Pemphigoid is a group of rare autoimmune blistering diseases of the skin and mucous membranes. As its name indicates, pemphigoid is similar in general appearance to pemphigus, however unlike pemphigus, pemphigoid does not feature acantholysis, a loss of connections between skin cells.
Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. Symptoms of these diseases can affect many different body systems, including joints, skin, kidneys, blood cells, heart, and lungs. The most common and most severe form is systemic lupus erythematosus.
Pemphigus foliaceus is an autoimmune blistering disease of the skin. Pemphigus foliaceus causes a characteristic inflammatory attack at the subcorneal layer of epidermis, which results in skin lesions that are scaly or crusted erosions with an erythematous (red) base. Mucosal involvement is absent even with widespread disease.
Chilblain lupus erythematosus was initially described by Hutchinson in 1888 as an uncommon manifestation of chronic cutaneous lupus erythematosus. Chilblain lupus erythematosus is characterized by a rash that primarily affects acral surfaces that are frequently exposed to cold temperatures, such as the toes, fingers, ears, and nose. The rash is defined by oedematous skin, nodules, and tender plaques with a purple discoloration.
Tumid lupus erythematosus is a rare, but distinctive entity in which patients present with edematous erythematous plaque.
Subacute cutaneous lupus erythematosus is a clinically distinct subset of cases of lupus erythematosus that is most often present in white women aged 15 to 40, consisting of skin lesions that are scaly and evolve as poly-cyclic annular lesions or plaques similar to those of plaque psoriasis.
Lupus erythematosus panniculitis presents with subcutaneous nodules that are commonly firm, sharply defined and nontender.
Lupus, technically known as systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary among people and may be mild to severe. Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face. Often there are periods of illness, called flares, and periods of remission during which there are few symptoms.
Majocchi's granuloma is a skin condition characterized by deep, pustular plaques, and is a form of tinea corporis. It is a localized form of fungal folliculitis. Lesions often have a pink and scaly central component with pustules or folliculocentric papules at the periphery. The name comes from Domenico Majocchi, who discovered the disorder in 1883. Majocchi was a professor of dermatology at the University of Parma and later the University of Bologna. This disease is most commonly caused by filamentous fungi in the genus Trichophyton.
Actinic granuloma (AG) was first described by O'Brien in 1975 as a rare granulomatous disease. Lesions appear on sun-exposed areas, usually on the face, neck, and scalp, with a slight preference for middle-aged women. They are typically asymptomatic, single or multiple, annular or polycyclic lesions measuring up to 6 cm in diameter, with slow centrifugal expansion, an erythematous elevated edge, and a hypopigmented, atrophic center.
Acute cutaneous lupus erythematosus is a cutaneous condition characterized by a bilateral malar rash and lesions that tend to be transient, and that follow sun exposure. The acute form is distinct from chronic and subacute cutaneous lupus erythematosus, which may have different types of skin lesions. Cutaneous lupus erythematosus is associated with both lupus erythematosus-specific lesions and cutaneous manifestations that are not specific to lupus erythematosus, such as oral ulcers and urticaria. Because of the diagnostic criteria used to diagnose systemic lupus erythematosus, a patient with only cutaneous manifestations may be diagnosed with the systemic form of the disease.
Lupus vasculitis is one of the secondary vasculitides that occurs in approximately 50% of patients with systemic lupus erythematosus (SLE).
Autoimmune skin diseases occur when the immune system of an infected animal attacks its own skin. In dogs, autoimmune skin diseases are usually not detected until visible symptoms appear, which differs from detection in humans who are able to verbally express their concerns. Genetics, nutrition, and external environmental factors all collectively contribute to increasing the probability an autoimmune skin disease occurring. The severity of symptoms varies based on the specific disease present and how far it has progressed. Diagnosis often requires the onset of visible symptoms and for a biopsy to be performed. For many diseases, the condition itself cannot be cured, but a veterinarian can prescribe medications and other forms of treatment to help manage the symptoms of the dog.